Asgar Ali

Dr. Asgar Ali

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Pharmacological Research
Verified
Journal Article
Closed access
EAEjaj Ahmad
Ejaj Ahmad
Asgar AliAsgar Ali
Asgar Ali
MFMunazza Tamkeen Fatima
Munazza Tamkeen Fatima
NINimisha
Nimisha
APApurva
Apurva
SSSundeep Singh Saluja
Sundeep Singh Saluja

9 August 2021 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
RDRinki Deb
Rinki Deb
RSRudra Pratap Singh
Rudra Pratap Singh
PMPrabhas Kumar Mishra
Prabhas Kumar Mishra
LHLisa Hitchins
Lisa Hitchins
EREmma Reid
Emma Reid
MCMichael Coleman
Michael Coleman
Background: In 2005, Bangladesh, India and Nepal agreed to eliminate visceral leishmaniasis (VL) as a public health problem. The approach to this was through improved case detection and treatment, and controlling transmission by the sand fly vector Phlebotomus argentipes, with indoor residual spraying (IRS) of insecticide. Initially, India applied DDT with stirrup pumps for IRS, however, this did not reduce transmission. After 2015 onwards, the pyrethroid alpha-cypermethrin was applied with compression pumps, and entomological surveillance was initiated in 2016. Methods: Eight sentinel sites were established in the Indian states of Bihar, Jharkhand and West Bengal. IRS coverage was monitored by household survey, quality of insecticide application was measured by HPLC, presence and abundance of the VL vector was monitored by CDC light traps, insecticide resistance was measured with WHO diagnostic assays and case incidence was determined from the VL case register KAMIS. Results: Complete treatment of houses with IRS increased across all sites from 57% in 2016 to 70% of houses in 2019, rising to >80% if partial house IRS coverage is included (except West Bengal). The quality of insecticide application has improved compared to previous studies, average doses of insecticide on filters papers ranged from 1.52 times the target dose of 25mg/m2 alpha-cypermethrin in 2019 to 1.67 times in 2018. Resistance to DDT has continued to increase, but the vector was not resistant to carbamates, organophosphates or pyrethroids. The annual and seasonal abundance of P. argentipes declined between 2016 to 2019 with an overall infection rate of 0.03%. This was associated with a decline in VL incidence for the blocks represented by the sentinel sites from 1.16 per 10,000 population in 2016 to 0.51 per 10,000 in 2019. Conclusion: Through effective case detection and management reducing the infection reservoirs for P. argentipes in the human population combined with IRS keeping P. argentipes abundance and infectivity low has reduced VL transmission. This combination of effective case management and vector control has now brought India within reach of the VL elimination targets.

12 August 2025 in Cells
Verified
Journal Article
Open access
PDF file
USUzma Saqib
Uzma Saqib
MPMonika Pandey
Monika Pandey
AVAnjali Vyas
Anjali Vyas
PPPreeti Patidar
Preeti Patidar
SHSumati Hajela
Sumati Hajela
Alexander G. ObukhovAlexander G. Obukhov
Alexander G. Obukhov
Lipoxins were discovered 40 years ago, and since then, their beneficial roles for human health have been confirmed in numerous studies. These small molecules belong to the eicosanoid class of compounds, which are generated metabolically by lipoxygenases. Lipoxins are released during various diseases and conditions, including but not limited to systemic inflammation, infection, asthma, cancer, diabetes, and cardiovascular disorders. Recently, several synthetic lipoxin analogs have been developed that also exhibit potent anti-inflammatory properties. In this review, we discuss the inflammation-resolving roles of lipoxins in various major diseases. Further, we summarize the latest reports on the use of synthetic lipoxins as potential therapeutic agents and discuss the role of aspirin-dependent lipoxin production in alleviating various diseases, including cancer.

20 June 2022 in Indian Journal of Clinical Biochemistry
Verified
Journal Article
Closed access
PDF file
BKBandana Kumari
Bandana Kumari
KHKrishnan S Hajela
Krishnan S Hajela
Asgar AliAsgar Ali
Asgar Ali
ASABHAY KUMAR SHARMA
ABHAY KUMAR SHARMA
RYRajesh Kumar Yadav
Rajesh Kumar Yadav
SSSADHANA SHARMA
SADHANA SHARMA

1 June 2021 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
RVRenu Verma
Renu Verma
RSReal Sumayya Abdul Sattar
Real Sumayya Abdul Sattar
NINimisha
Nimisha
APApurva
Apurva
AKArun Kumar
Arun Kumar
SSSundeep Singh Saluja
Sundeep Singh Saluja

23 December 2021 in Current Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
QZQamar Zia
Qamar Zia
MAMohammad Asim Azhar
Mohammad Asim Azhar
NHNazia Hassan
Nazia Hassan
PJPooja Jain
Pooja Jain
MSManvi Singh
Manvi Singh
AJazfar jamal
azfar jamal